Arshad Khanani, MD
Enriched profileManaging Partner, Director of Clinical Research, and Director of Fellowship, Sierra Eye Associates; Clinical Professor, University of Nevada, Reno School of Medicine · Sierra Eye Associates
Arshad Khanani is Managing Partner, Director of Clinical Research, and Director of Fellowship, Sierra Eye Associates; Clinical Professor, University of Nevada, Reno School of Medicine at Sierra Eye Associates. OpenAlex indexes 163 publications with 5,354 citations (h-index 34); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Arshad M. Khanani, MD, is Managing Partner, Director of Clinical Research, and Director of Fellowship, Sierra Eye Associates. The public record shows 163 publications with 5,354 citations (h-index 34), centered on Retinal Diseases and Treatments, Ophthalmology and Visual Impairment Studies, Retinal Imaging and Analysis. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 43 companies.
- Most recent indexed publication: 2026 · Eye (London, England)
- Top research focus: Retinal Diseases and Treatments
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 43 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 83.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor: 4D Molecular Therapeutics
- Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
Sponsor: Sierra Eye Associates
- Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Sponsor: i-Lumen Scientific AUS PTY LTD
Industry payments
Updated 27 Aug 2026
43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Ocular Therapeutix, Inc.Program year202590 payments$115,232openpaymentsdata.cms.gov ↗
- Astellas Pharma US IncProgram year202536 payments$107,663openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year202518 payments$51,025openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
99.9%Antineovascularisation agents94.2%Faricimab-svoa100%Part B, office-administered≥561 patientsComplement Inhibitor4.3%Avacincaptad pegol100%Part B, office-administered≥107 patientsCancer & immunology
0.1%Vascular Endothelial Growth Factor Inhibitor0.1%Aflibercept77%Bevacizumab23%Part B, office-administered≥24 patientsCardiovascular
0%Beta blocker0%Timolol Maleate100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensus.
Eye (London, England)
Article2026 - Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis.
Clinical ophthalmology (Auckland, N.Z.)
Article2026 - A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights.
Eye (London, England)
Article2026 - Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study.
Eye (London, England)
Article2025
Most-cited works
by citation count (OpenAlex)- 02
- 03
- 04TENAYA and LUCERNE188 citations2024
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/arshad-khanani-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/arshad-m-khanani-977596104
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
asrs.org/find-a-specialist/profile/8313/Arshad-M-Khanani
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗ - Other
healio.com/cme/mededtalks/ophthalmology/20241210/11-the-retina-radar-with-dr-arshad-khanani-emerging-therapeutics-in-late-stage-development/overview
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Texas Tech University Health Sciences Center School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- Ophthalmology residency
Texas Tech University Health Sciences Center (Chief Resident)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Vitreoretinal fellowship
UT Southwestern Medical Center, Dallas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Board certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Editorial & leadership roles
journal and society appointments- Member
Macula Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗ - Member
Retina Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗ - Chair
Phase 3 GATHER2 Steering Committee (IZERVAY, geographic atrophy)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor
University of Nevada, Reno School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sierraeyeassociates.com ↗ - Scientific Advisory Board
Clearside Biomedical
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.clearsidebio.com ↗ - Team/Advisory role
4D Molecular Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →4dmoleculartherapeutics.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theophthalmologist.com ↗
- Host
"The Retina Radar with Dr. Arshad Khanani" video podcast series (Healio)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - Guest
"Retina Matters" video podcast (geographic atrophy OLE trial discussion)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore